Melvin Colón has been a dedicated professional in the pharmaceutical industry since 1997. Since 2002, he has held the position of Senior Quality Assurance Consultant and CEO at MCD Consulting Services. Mr. Colón is recognized as a distinguished expert in pharmaceutical consulting.

With over twenty-eight years of industry experience, Mr. Colón provides expert regulatory guidance to clients worldwide, helping them navigate the complexities of bringing new medical products to market. 

Mr. Colón is a licensed chemist with a proven track record of success across the pharmaceutical, biotechnology, including cell and gene therapy, biosimilars, and medical device industries, including combination products. His expertise includes Quality Assurance, Quality Control, Quality Systems (such as Deviations, CAPA, and Change Control), Validation, Regulatory Compliance, Risk Assessments, Manufacturing Operations, Project Management, OOS and OOTs, Documentation Control, Sterility Assurance, Cleaning Validation, Electronic Batch Records, and internal and external audits of CMO and supplier facilities. Additionally, he has extensive experience in remediation activities related to Consent Decrees and sites with regulatory observations (Warning Letters and 483s). 

Mr. Colón poses Strong background in Solid Dosage (Tablets/Capsules), Medical Devices, Combination of Products, Biotechnology, Biosimilar, Cell & Gene Therapy, Parenteral,  Analytical Testing, Microbiology, Validation, Product Development, and Product Transfer in Aseptic Manufacturing (Microbiology, Environmental Monitoring, Media Fill, Sterilization, Autoclaves, Vial Washer, Depyrogenation tunnels, Lyophilizer, Smoke Studies, Aseptic Area Qualification),  Solid Dosage Manufacturing and Packaging (granulation, blending, milling, micronization, compression, coating, blister, samples, and bottles lines), Liquids, Quality Assurance, Technical Services, and Planning area. Process Investigation (creation, evaluation, and approval), Qualification of Facilities and Equipment (IQ/OQ/PQ)/ Change Controls. CAPA, Complaints, Audits (Internal, Supplier, CMO, Regulatory), Data Integrity.

In his project, Mr. Colón is responsible for supporting site readiness and Pre-approval Inspection at a facility in Serbia. On his previous project, he was responsible for preparing responses to one of the FDA observations for 483s and managing related cleaning validation remediation activities, including organizational restructuring for a client in Iceland. Additionally, Mr. Colón has played a key role in advising a vaccine manufacturer in Mexico, where his keen attention to regulatory details identified significant process gaps resulting in no rejected lots in the last campaign. His ability to recommend effective solutions has helped his clients succeed during inspections. His international experience includes working with pharmaceutical companies in Japan, Brazil, Iceland, China, Korea, India, and other markets worldwide, as well as the United States. He was part of a leadership team that transformed a clinical site into a commercial facility, earning the first GMP certification and FDA approval for commercial cell and gene therapy products in the USA.

Mr. Colón earned a Bachelor of Science in industrial chemistry from the University of Puerto Rico in 1997. He later obtained a master’s degree in engineering management from the Polytechnic University of Puerto Rico in 2000, followed by a Master of Science in manufacturing competitiveness in 2010. 

Throughout his career, Mr. Colón has held senior QA and compliance roles with many organizations, including The FDA Group, The Henrici Group, LST Consulting USA, Pharma BioServ, and others. His early success as a consultant earned recognition from numerous clients and several performance awards, as noted on his LinkedIn profile.

Outside of his professional pursuits, Mr. Colón is a dedicated husband and passionate dog lover who shares his home with 12 dogs. He enjoys traveling and immersing himself in different cultures, both for work and leisure. 

Looking ahead, Mr. Colón remains committed to ensuring that companies around the world are thoroughly prepared for regulatory inspections. His work plays a critical role in helping life-saving medical innovations reach the patients who need them.